Exploring the Regulatory Effects of Curcumin on CD47-Overexpressing Esophageal Cancer Cells via Network Pharmacology withPreclinical Validation
This study highlights CUR's potential in treating EC, particularly in CD47 overexpression cases. These results clarify the molecular interactions and provide a basis for future research on CUR-based therapies targeting EC progression pathways.
Authors
- Hongchao Zhen
- J R Wang
- Yan Kang
- Xiao Li
- Haishan Lin
Institutions
- Shanghai Liangyou (China) (CN)
- Beijing Friendship Hospital (CN)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2026-01-13
- DOI
- https://doi.org/10.2174/0109298673422903251129071114
- Primary Topic
- Phagocytosis and Immune Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00